Health Care & Life Sciences » Pharmaceuticals | Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. | Mutual Funds

Mutual Funds that own Sun Pharmaceutical Industries Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ICICI Prudential Value Discovery Fund
30,000,000
1.25%
-2,818,042
11.3%
08/31/2018
Matthews Pacific Tiger Fund
20,654,758
0.86%
1,400,000
2.09%
06/29/2018
Vanguard Emerging Markets Stock Index Fund
16,955,452
0.71%
-121,520
0.19%
07/31/2018
Vanguard Total International Stock Index Fund
15,534,445
0.65%
180,077
0.04%
07/31/2018
Emerging Markets Fund of the Genesis Group Trust for Employee
12,972,872
0.54%
997,753
1.41%
12/31/2016
SBI Blue Chip Fund
9,838,846
0.41%
1,000,000
3.17%
06/30/2018
9,334,395
0.39%
187,820
1.56%
06/30/2018
Axis Long Term Equity Fund
8,924,128
0.37%
250,000
3.12%
07/31/2018
Fidelity Series Emerging Markets Fund
8,906,984
0.37%
-925,200
0.61%
07/31/2018
Genesis Emerging Markets Investment Co. - Global Sub Fund
8,829,565
0.37%
-4,698,788
1.19%
12/31/2017

About Sun Pharmaceutical Industries

View Profile
Address
CTS No. 201 B/1, Sun House
Mumbai Maharashtra 400063
India
Employees -
Website http://www.sunpharma.com
Updated 07/08/2019
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It operates through the following geographical segments: India, United States of America, Emerging Markets, and Rest of the World. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.